Free Access To High-Cost Aducanumab May Incentivize Phase IV Trial Participants

Accelerated Approval Adds Another Alzheimer’s Study To Global Pipeline

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.